Skip to main content

Affymetrix to Supply Genotyping Tech for EverGene's Personal Genomics Services in Japan

NEW YORK (GenomeWeb) – Affymetrix today announced that it has signed a deal to collaborate with MTI subsidiary EverGene on a personal genomics service for the Japanese market.

Under the deal, Affymetrix's Axiom genotyping platform will be used with EverGene's DearGene Starter Kit, a consumer genotyping service that provides information about an individual's risk for disease. Samples for the kit are processed exclusively by Takara Bio, according to a joint statement released by Affy and EverGene.

Financial terms of the supply agreement were not disclosed.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.